Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/HCTZ FDC vs Telmisartan in Hypertension Non-Responders
NCT02177500Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2000
- Primary completion
- May 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telmisartan, hydrochlorothiazide in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Jan 2000; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02177500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177500.